FOXP1 protein expression has been detected in 40-60% of DLBCL cases, and strong expression of FOXP1 has been associated with poorer prognosis in patients with some B-cell lymphomas [16], [17]. The gene discussed is FOXP1; the disease is diffuse large B-cell lymphoma.